Richard Godfrey, CEO of BerGenBio, to chair Oncology 2025 supersession at Nordic Life Science Days

Richard Godfrey has been invited to chair the Oncology 2025 supersession during the Nordic Life Science Days in Stockholm, Sweden, Sep 9-10 2015. The conference is the largest Nordic partnering conference for the global Life Science industry and the session gathers industry leaders to discuss trends within immune-oncology, novel business models and methods for patient stratification.
 
Description of session
 
Oncology is at the forefront of realising the promises of precision medicine. Huge and complex datasets are exploited for novel drug development as well as for informed and real-time care decisions. Emerging Cancer immunotherapies represent a paradigm shift for cancer treatment triggering a global R&D race and novel partnerships. Furthermore, the convergence of the genetics and digital revolution creates novel types of products, companies and growth opportunities transforming the sector.
In this session, international thought leaders will discuss current game changing innovations and their impact on the industry in the years ahead. Special focus will be on novel partnering and collaboration models to advance innovations towards a changing market.